{"id":"NCT00356603","sponsor":"GlaxoSmithKline","briefTitle":"Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan","officialTitle":"Imigran STATdose - Japan Clinical Experience Study for Self-injection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06-20","primaryCompletion":"2006-08-07","completion":"2006-08-07","firstPosted":"2006-07-26","resultsPosted":"2017-11-20","lastUpdate":"2018-09-04"},"enrollment":75,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders"],"interventions":[{"type":"DRUG","name":"Sumatriptan Succinate","otherNames":[]}],"arms":[{"label":"Sumatriptan","type":"EXPERIMENTAL"}],"summary":"This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection.","primaryOutcome":{"measure":"Percentage of Participants With Headache Relief at 60 Minutes Post Dose(Migraine) or 30 Minutes Post Dose(Cluster Headache)","timeFrame":"30 minutes or 60 Minutes after each administration","effectByArm":[{"arm":"Migraine","deltaMin":93.9,"sd":null},{"arm":"Cluster Headache","deltaMin":93.9,"sd":null},{"arm":"Migraine + Cluster Headache","deltaMin":93.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":4,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":["Malaise","Nausea","Blood creatine phosphokinase increased","Asthenia","Nasopharyngitis"]}}